KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Sales (2019 - 2025)

GoodRx Holdings' Return on Sales history spans 7 years, with the latest figure at 0.03% for Q4 2025.

  • For Q4 2025, Return on Sales fell 1.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.04%, up 2.0%, while the annual FY2025 figure was 0.04%, 2.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.03% at GoodRx Holdings, up from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.31% in Q2 2023 and bottomed at 0.22% in Q3 2022.
  • The 5-year median for Return on Sales is 0.01% (2025), against an average of 0.0%.
  • The largest annual shift saw Return on Sales surged 176bps in 2021 before it dropped -28bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.19% in 2021, then skyrocketed by 94bps to 0.01% in 2022, then crashed by -1128bps to 0.13% in 2023, then skyrocketed by 126bps to 0.03% in 2024, then fell by -18bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Return on Sales are 0.03% (Q4 2025), 0.01% (Q3 2025), and 0.06% (Q2 2025).